Recent studies have shown that the interaction between CD80 and PD-L1 interferes with the binding of PD-L1 of tumor cells to the inhibitory receptor PD-1 on T cells, thereby promoting the immune response of T cells (20). Here, CD274 is linked to neoplasm.